Credit: Luis Tato / AFP via Getty Images

Coronavirus (COVID-19): supporting global research and development

We want to help the world overcome the COVID-19 pandemic. We're supporting research and development, and working to make sure that any new vaccines, tests and treatments are mass-produced quickly and reach everyone who needs them.

Urgent investment is needed

Investing now, at scale and as a collective global effort is vital to change the course of the pandemic.

At least $8 billion of new funding is needed for the global response to COVID-19 – for research, development and supply of treatments for all, and support for public health measures in countries with the weakest health systems.

How businesses can join the response

Businesses can invest in and advocate for research and development by joining COVID-Zero, a global coalition of partners launched by Wellcome.

Research is the world's best exit strategy

Research is the best way to save lives, bring the COVID-19 pandemic to an end and prevent it reappearing.

We’re supporting global research efforts – including the development of vaccines and treatments, and epidemic preparedness in low- and middle-income countries.

We're also calling on researchers, journals and funders to share their research data and findings rapidly and openly. 

Access to vaccines, tests and treatments for all

All R&D funders, developers, manufacturers and governments must help to make sure that new vaccines, tests and treatments developed for COVID-19 are globally available, appropriate and affordable for everyone, regardless of where they have been developed or who has funded them.

Latest news

More news

Read more articles on COVID-19.


Information for grant applicants and grantholders

While the Wellcome Trust building has closed, we remain very much open for business. Here's what you need to know if you're applying for one of our research grants, or hold a Wellcome grant.

Contact us

Sign up to our newsletter